Factors associated with placenta praevia in primigravidas and its pregnancy outcome

Nur Azurah Abdul Ghani, Zakaria Wan Zainol, Pei Shan Lim, Mohamad Nasir Shafiee, Nirmala @ Chandralega Kampan, Wan Syahirah Mohsin, Norfilza Mohd Mokhtar, Muhammad Abdul Jamil Muhammad Yassin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aim. To examine the factors associated with placenta praevia in primigravidas and also compare the pregnancy outcomes between primigravidas and nonprimigravidas. Method. A retrospective cohort study was conducted in women who underwent caesarean section for major placenta praevia in a tertiary university hospital from January 2007 till December 2013. Medical records were reviewed. Result. Among 243 with major placenta praevia, 56 (23.0%) were primigravidas and 187 (77.0%) were nonprimigravidas. Factors associated with placenta praevia in the primigravidas were history of assisted conception (P = 0.02) and history of endometriosis (P = 0.01). For maternal outcomes, the nonprimigravidas required earlier delivery than primigravidas (35.76 ± 2.54 weeks versus 36.52 ± 1.95 weeks, P = 0.03) and had greater blood loss (P = 0.04). A vast majority of the primigravidas had either posterior type II or type III placenta praevia. As for neonatal outcomes, the Apgar score at 1 minute was significantly lower for the nonprimigravidas (7.89 ± 1.72 versus 8.39 ± 1.288.39 ± 1.28, P = 0.02). Conclusion. This study highlighted that endometriosis and assisted conception were highly associated with placenta praevia in primigravida. Understanding the pregnancy outcomes of women with placenta praevia can assist clinicians in identifying patients who are at higher risk of mortality and morbidity. Identifying potential risk factors in primigravida may assist in counseling and management of such patients.

Original languageEnglish
Article number270120
JournalScientific World Journal
Volume2014
DOIs
Publication statusPublished - 2014

Fingerprint

Placenta Previa
Pregnancy Outcome
pregnancy
History
morbidity
history
risk factor
Blood
blood
mortality
Endometriosis
Apgar Score
woman
Tertiary Care Centers
Cesarean Section
Medical Records
Counseling
Cohort Studies
Retrospective Studies
Mothers

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Environmental Science(all)
  • Medicine(all)

Cite this

Factors associated with placenta praevia in primigravidas and its pregnancy outcome. / Abdul Ghani, Nur Azurah; Wan Zainol, Zakaria; Lim, Pei Shan; Shafiee, Mohamad Nasir; Kampan, Nirmala @ Chandralega; Mohsin, Wan Syahirah; Mohd Mokhtar, Norfilza; Muhammad Yassin, Muhammad Abdul Jamil.

In: Scientific World Journal, Vol. 2014, 270120, 2014.

Research output: Contribution to journalArticle

@article{d969f1eb9baa4640bdb950a8429f0c74,
title = "Factors associated with placenta praevia in primigravidas and its pregnancy outcome",
abstract = "Aim. To examine the factors associated with placenta praevia in primigravidas and also compare the pregnancy outcomes between primigravidas and nonprimigravidas. Method. A retrospective cohort study was conducted in women who underwent caesarean section for major placenta praevia in a tertiary university hospital from January 2007 till December 2013. Medical records were reviewed. Result. Among 243 with major placenta praevia, 56 (23.0{\%}) were primigravidas and 187 (77.0{\%}) were nonprimigravidas. Factors associated with placenta praevia in the primigravidas were history of assisted conception (P = 0.02) and history of endometriosis (P = 0.01). For maternal outcomes, the nonprimigravidas required earlier delivery than primigravidas (35.76 ± 2.54 weeks versus 36.52 ± 1.95 weeks, P = 0.03) and had greater blood loss (P = 0.04). A vast majority of the primigravidas had either posterior type II or type III placenta praevia. As for neonatal outcomes, the Apgar score at 1 minute was significantly lower for the nonprimigravidas (7.89 ± 1.72 versus 8.39 ± 1.288.39 ± 1.28, P = 0.02). Conclusion. This study highlighted that endometriosis and assisted conception were highly associated with placenta praevia in primigravida. Understanding the pregnancy outcomes of women with placenta praevia can assist clinicians in identifying patients who are at higher risk of mortality and morbidity. Identifying potential risk factors in primigravida may assist in counseling and management of such patients.",
author = "{Abdul Ghani}, {Nur Azurah} and {Wan Zainol}, Zakaria and Lim, {Pei Shan} and Shafiee, {Mohamad Nasir} and Kampan, {Nirmala @ Chandralega} and Mohsin, {Wan Syahirah} and {Mohd Mokhtar}, Norfilza and {Muhammad Yassin}, {Muhammad Abdul Jamil}",
year = "2014",
doi = "10.1155/2014/270120",
language = "English",
volume = "2014",
journal = "Scientific World Journal",
issn = "2356-6140",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Factors associated with placenta praevia in primigravidas and its pregnancy outcome

AU - Abdul Ghani, Nur Azurah

AU - Wan Zainol, Zakaria

AU - Lim, Pei Shan

AU - Shafiee, Mohamad Nasir

AU - Kampan, Nirmala @ Chandralega

AU - Mohsin, Wan Syahirah

AU - Mohd Mokhtar, Norfilza

AU - Muhammad Yassin, Muhammad Abdul Jamil

PY - 2014

Y1 - 2014

N2 - Aim. To examine the factors associated with placenta praevia in primigravidas and also compare the pregnancy outcomes between primigravidas and nonprimigravidas. Method. A retrospective cohort study was conducted in women who underwent caesarean section for major placenta praevia in a tertiary university hospital from January 2007 till December 2013. Medical records were reviewed. Result. Among 243 with major placenta praevia, 56 (23.0%) were primigravidas and 187 (77.0%) were nonprimigravidas. Factors associated with placenta praevia in the primigravidas were history of assisted conception (P = 0.02) and history of endometriosis (P = 0.01). For maternal outcomes, the nonprimigravidas required earlier delivery than primigravidas (35.76 ± 2.54 weeks versus 36.52 ± 1.95 weeks, P = 0.03) and had greater blood loss (P = 0.04). A vast majority of the primigravidas had either posterior type II or type III placenta praevia. As for neonatal outcomes, the Apgar score at 1 minute was significantly lower for the nonprimigravidas (7.89 ± 1.72 versus 8.39 ± 1.288.39 ± 1.28, P = 0.02). Conclusion. This study highlighted that endometriosis and assisted conception were highly associated with placenta praevia in primigravida. Understanding the pregnancy outcomes of women with placenta praevia can assist clinicians in identifying patients who are at higher risk of mortality and morbidity. Identifying potential risk factors in primigravida may assist in counseling and management of such patients.

AB - Aim. To examine the factors associated with placenta praevia in primigravidas and also compare the pregnancy outcomes between primigravidas and nonprimigravidas. Method. A retrospective cohort study was conducted in women who underwent caesarean section for major placenta praevia in a tertiary university hospital from January 2007 till December 2013. Medical records were reviewed. Result. Among 243 with major placenta praevia, 56 (23.0%) were primigravidas and 187 (77.0%) were nonprimigravidas. Factors associated with placenta praevia in the primigravidas were history of assisted conception (P = 0.02) and history of endometriosis (P = 0.01). For maternal outcomes, the nonprimigravidas required earlier delivery than primigravidas (35.76 ± 2.54 weeks versus 36.52 ± 1.95 weeks, P = 0.03) and had greater blood loss (P = 0.04). A vast majority of the primigravidas had either posterior type II or type III placenta praevia. As for neonatal outcomes, the Apgar score at 1 minute was significantly lower for the nonprimigravidas (7.89 ± 1.72 versus 8.39 ± 1.288.39 ± 1.28, P = 0.02). Conclusion. This study highlighted that endometriosis and assisted conception were highly associated with placenta praevia in primigravida. Understanding the pregnancy outcomes of women with placenta praevia can assist clinicians in identifying patients who are at higher risk of mortality and morbidity. Identifying potential risk factors in primigravida may assist in counseling and management of such patients.

UR - http://www.scopus.com/inward/record.url?scp=84912553189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912553189&partnerID=8YFLogxK

U2 - 10.1155/2014/270120

DO - 10.1155/2014/270120

M3 - Article

C2 - 25478587

AN - SCOPUS:84912553189

VL - 2014

JO - Scientific World Journal

JF - Scientific World Journal

SN - 2356-6140

M1 - 270120

ER -